Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,58 USD | +0,65% | -2,02% | -4,90% |
Omzet 2024 * | - | Omzet 2025 * | 16,49 mln. 15,51 mln. | Marktkapitalisatie | 485 mln. 456 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -114 mln. -107 mln. | Nettowinst (verlies) 2025 * | -110 mln. -103 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 218 mln. 205 mln. | Nettoliquiditeiten 2025 * | 105 mln. 98,45 mln. | EV/omzet 2025 * | 23,1 x |
K/w-verhouding 2024 * |
-3,78
x | K/w-verhouding 2025 * |
-4,82
x | Werknemers | 118 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,86% |
Recentste transcriptie over KalVista Pharmaceuticals, Inc.
1 dag | -1,29% | ||
1 week | -4,96% | ||
Lopende maand | -3,04% | ||
1 maand | -4,09% | ||
3 maanden | -7,70% | ||
6 maanden | +25,68% | ||
Lopend jaar | -6,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26-03-04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01-08-16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01-02-19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01-08-16 |
Albert Cha
BRD | Director/Board Member | 51 | 01-01-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.03% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | +4,47% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 11,7 | +1,70% | 19 463 |
18-04-24 | 11,5 | -1,29% | 408 659 |
17-04-24 | 11,65 | -1,94% | 298 729 |
16-04-24 | 11,88 | +1,19% | 489 733 |
15-04-24 | 11,74 | -1,26% | 313 461 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,12% | 485 mln. | |
-5,99% | 84,46 mld. | |
+3,95% | 40,85 mld. | |
-26,37% | 27,69 mld. | |
+52,09% | 24,28 mld. | |
-6,59% | 17,09 mld. | |
-32,37% | 13,67 mld. | |
-10,45% | 11,79 mld. | |
-15,88% | 11,86 mld. | |
-2,85% | 8,07 mld. |